Maxcyte (MXCT) EBITDA Margin (2020 - 2026)
Maxcyte (MXCT) reported EBITDA Margin of 53.41% for Q1 2026, up 14176.0% year-over-year from N/an in Q1 2025, and up 92.13% on a QoQ basis from 678.42% in Q4 2025.
Maxcyte (MXCT) has 7 years of EBITDA Margin data on file, last reported at 53.41% in Q1 2026.
- Quarterly EBITDA Margin rose 14176.0% year-over-year to 53.41% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 5.53% (up 2117.0% YoY) and the FY2025 annual result came in at 24.26%, down 1321.0% from the prior year.
- EBITDA Margin improved to 53.41% in Q1 2026 per MXCT's latest filing, from 678.42% in the prior quarter.
- Across five years, EBITDA Margin topped out at 353.96% in Q4 2024 and bottomed at 678.42% in Q4 2025.
- The 5-year median for EBITDA Margin is 170.23% (2023), against an average of 148.28%.
- The widest annual swing landed in 2024, when EBITDA Margin jumped 52419 bps; it then tumbled 103239 bps in 2025.
- Tracing MXCT's EBITDA Margin over 5 years: stood at 218.48% in 2022, then slumped by 178 bps to 170.23% in 2023, then jumped by 308 bps to 353.96% in 2024, then slumped by 292 bps to 678.42% in 2025, then surged by 92 bps to 53.41% in 2026.
- Per Business Quant, the three latest MXCT EBITDA Margin figures stand at 53.41% (Q1 2026), 678.42% (Q4 2025), and 191.71% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | Maxcyte | 129.85 Mn | 129.85 Mn | 8.08 Mn | -53.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53.41% |
| Dec 31, 2025 | -678.42% |
| Sep 30, 2025 | -191.71% |
| Jun 30, 2025 | -225.58% |
| Mar 31, 2025 | -195.18% |
| Dec 31, 2024 | 353.96% |
| Sep 30, 2024 | -159.08% |
| Jun 30, 2024 | -219.32% |
| Mar 31, 2024 | -219.82% |
| Dec 31, 2023 | -170.23% |
| Sep 30, 2023 | -335.71% |
| Jun 30, 2023 | -144.56% |
| Mar 31, 2023 | -265.47% |
| Dec 31, 2022 | 218.48% |
| Sep 30, 2022 | -107.83% |
| Jun 30, 2022 | -90.96% |
| Mar 31, 2022 | -35.89% |
| Dec 31, 2021 | 228.28% |
| Sep 30, 2021 | -43.56% |
| Jun 30, 2021 | -62.14% |
| Mar 31, 2021 | -150.34% |
| Dec 31, 2020 | -281.10% |
| Sep 30, 2020 | -60.87% |
| Jun 30, 2020 | -122.28% |